| | |
Page
|
| |||
ABOUT THIS PROSPECTUS
|
| | | | ii | | |
INDUSTRY AND MARKET DATA
|
| | | | ii | | |
PROSPECTUS SUMMARY
|
| | | | 1 | | |
THE OFFERING
|
| | | | 10 | | |
RISK FACTORS
|
| | | | 12 | | |
有关前瞻性陈述的警示说明
|
| | | | 45 | | |
USE OF PROCEEDS
|
| | | | 47 | | |
DIVIDEND POLICY
|
| | | | 48 | | |
DILUTION
|
| | | | 49 | | |
管理层对财务状况和经营成果的讨论和分析
|
| | | | 51 | | |
BUSINESS
|
| | | | 65 | | |
MANAGEMENT
|
| | | | 88 | | |
高管和董事薪酬
|
| | | | 94 | | |
某些受益所有者和管理层的担保所有权
|
| | | | 102 | | |
SELLING STOCKHOLDER
|
| | | | 104 | | |
某些关系和关联方交易
|
| | | | 106 | | |
股本说明
|
| | | | 108 | | |
PLAN OF DISTRIBUTION
|
| | | | 113 | | |
林肯公园交易
|
| | | | 115 | | |
LEGAL MATTERS
|
| | | | 120 | | |
EXPERTS
|
| | | | 120 | | |
披露证监会对证券法责任赔偿的立场
|
| | | | 120 | | |
您可以在哪里找到更多信息
|
| | | | 120 | | |
PAXMEDICA,Inc.财务报表索引
|
| | | | F-1 | | |
|
假定每股发行价
|
| | | $ | 1.55 | | |
|
2022年9月30日普通股每股有形账面净值
|
| | | $ | 0.20 | | |
|
可归因于此次发行的普通股每股有形账面净值增加
|
| | | $ | 0.69 | | |
|
本次发行后普通股每股预计有形账面净值
|
| | | $ | 0.89 | | |
|
在此次发行中向新投资者摊薄每股普通股
|
| | | $ | 0.66 | | |
| | |
截至9月30日的三个月
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
Operating expenses | | | | | | | | | | | | | |
一般和行政
|
| | | $ | 2,367,711 | | | | | $ | 1,277,287 | | |
研发
|
| | | | 327,268 | | | | | | 437,559 | | |
总运营费用
|
| | | | 2,694,979 | | | | | | 1,714,846 | | |
Loss from operations
|
| | | | (2,694,979) | | | | | | (1,714,846) | | |
Other expense, net
|
| | | | (8,768,634) | | | | | | (1,395,796) | | |
Net loss
|
| | | $ | (11,463,613) | | | | | $ | (3,110,642) | | |
| | |
截至9月30日的9个月
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
Operating expenses | | | | | | | | | | | | | |
一般和行政
|
| | | $ | 4,077,491 | | | | | $ | 3,651,218 | | |
研发
|
| | | | 1,549,397 | | | | | | 1,755,428 | | |
总运营费用
|
| | | | 5,626,888 | | | | | | 5,406,646 | | |
Loss from operations
|
| | | | (5,626,888) | | | | | | (5,406,646) | | |
Other expense, net
|
| | | | (3,954,231) | | | | | | (11,055,581) | | |
Net loss
|
| | | $ | (9,581,119) | | | | | $ | (16,462,227) | | |
| | |
Years Ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Operating expenses | | | | | | | | | | | | | |
一般和行政
|
| | | $ | 4,973,245 | | | | | $ | 4,629,070 | | |
研发
|
| | | | 2,224,555 | | | | | | 936,776 | | |
总运营费用
|
| | | | 7,197,800 | | | | | | 5,565,846 | | |
Loss from operations
|
| | | | (7,197,800) | | | | | | (5,565,846) | | |
Other expense, net
|
| | | | (3,031,171) | | | | | | (2,260,162) | | |
Net loss
|
| | | $ | (10,228,971) | | | | | $ | (7,826,008) | | |
仪器系数或
behavior |
| |
Treatment
(days) |
| |
Difference
from baseline (mean ± SD) |
| |
95% CI
|
| |
d(1)
|
| |
N
|
| |
P(2)
|
| |
P(3)
|
| |
Difference
from baseline (mean ± SD) |
| |
95% CI
|
| |
d(1)
|
| |
N
|
| |
P(2)
|
| |
p(3)
|
| |||
Primary outcomes | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||
ADOS-2 | | | Comparison | | |
45
|
| |
-1.6 ± 0.55
|
| |
-2.3 to -0.9
|
| |
2.9
|
| |
5
|
| |
0.0028
|
| |
0.038
|
| |
-0.4 ± 0.55
|
| |
-1.1 to + 0.28
|
| |
0.7
|
| |
5
|
| |
0.18
|
| |
0.16
|
|
| | | Raw | | |
45
|
| |
-4.6 ± 1.9
|
| |
-7.0. to -2.2
|
| |
2.4
|
| |
5
|
| |
0.0062
|
| |
0.039
|
| |
-0.4 ± 1.8
|
| |
-2.7 to +1.9
|
| |
0.22
|
| |
5
|
| |
0.65
|
| |
0.58
|
|
| | | Social | | |
45
|
| |
-3.2 ± 1.9
|
| |
-5.6 to -0.8
|
| |
2.4
|
| |
5
|
| |
0.020
|
| |
0.043
|
| |
0.0 ± 1.7
|
| |
-2.2 to +2.2
|
| |
0
|
| |
5
|
| |
0.99
|
| |
0.71
|
|
| | | Rest/Rep | | |
45
|
| |
-1.4 ± 0.89
|
| |
-2.5 to -0.29
|
| |
1.6
|
| |
5
|
| |
0.025
|
| |
0.059
|
| |
-0.4 ± 2.1
|
| |
-3.0 to +2.2
|
| |
0.19
|
| |
5
|
| |
0.69
|
| |
0.58
|
|
EOWPVT
|
| | Vocabulary | | |
45
|
| |
-4.2 ± -8.3
|
| |
-14.50 to +6.1
|
| |
-0.51
|
| |
5
|
| |
0.32
|
| |
0.50
|
| |
+2.0 ± 4.6
|
| |
-3.8 to +7.8
|
| |
0.43
|
| |
5
|
| |
0.39
|
| |
0.50
|
|
Secondary Outcomes | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||
ABC
|
| | Stereotypy | | |
7
|
| |
36 ± 2.1
|
| |
-6.2 to -1.0
|
| |
1.7
|
| |
5
|
| |
0.018
|
| |
0.043
|
| |
+0.4 ± 1.9
|
| |
-2.0 to +2.5
|
| |
-0.21
|
| |
5
|
| |
0.67
|
| |
0.68
|
|
Stereotypy
|
| | | | |
45
|
| |
-4.0 ± 2.3
|
| |
-6.9 to -1.1
|
| |
1.7
|
| |
5
|
| |
0.019
|
| |
0.042
|
| |
+1.0 ± 4.3
|
| |
4.3 to +6.3
|
| |
-0.23
|
| |
5
|
| |
0.63
|
| |
0.69
|
|
ATEC
|
| | Total | | |
7
|
| |
-10 ± 7.7
|
| |
-20 to -0.46
|
| |
1.3
|
| |
5
|
| |
0.044
|
| |
0.043
|
| |
+7.2 ± 14
|
| |
-10 to +25
|
| |
-0.51
|
| |
5
|
| |
0.32
|
| |
0.35
|
|
| | | Language | | |
7
|
| |
-2.2 ± 1.5
|
| |
-4.0 to -0.36
|
| |
1.4
|
| |
5
|
| |
0.021
|
| |
0.059
|
| |
0.0 ± 4.1
|
| |
-5.0 to +5.0
|
| |
0
|
| |
5
|
| |
0.99
|
| |
0.89
|
|
| | | Sociability | | |
7
|
| |
-3.6 ± 2.6
|
| |
-6.8 to -0.36
|
| |
1.4
|
| |
5
|
| |
0.025
|
| |
0.063
|
| |
-0.8 ± 2.8
|
| |
4.3 to +2.6
|
| |
0.29
|
| |
5
|
| |
0.55
|
| |
0.58
|
|
| | | Language | | |
45
|
| |
-2.0 ± 1.4
|
| |
-2.7 to -0.49
|
| |
1.4
|
| |
5
|
| |
0.034
|
| |
0.059
|
| |
-0.2 ± 2.9
|
| |
-3.8 to +3.4
|
| |
0.07
|
| |
5
|
| |
0.88
|
| |
0.79
|
|
CGI
|
| |
Overall ASD
|
| |
45
|
| |
-1.8 ± 1.04
|
| |
-3.4 to -0.15
|
| |
1.7
|
| |
5
|
| |
0.05
|
| |
n/a
|
| |
0.0 ± 0.34
|
| |
-0.55 to +0.55
|
| |
0
|
| |
5
|
| |
0.99
|
| |
n/a
|
|
| | |
E. Language
|
| |
45
|
| |
-2.0 ± 1.04
|
| |
-3.6 to -0.35
|
| |
1.9
|
| |
5
|
| |
0.01
|
| |
n/a
|
| |
0.0 ± 0.34
|
| |
-0.55 to +0.55
|
| |
0
|
| |
5
|
| |
0.99
|
| |
n/a
|
|
| | |
Social Inter.
|
| |
45
|
| |
-2.0 ± 1.04
|
| |
-3.6 to -0.35
|
| |
1.9
|
| |
5
|
| |
0.01
|
| |
n/a
|
| |
0.0 ± 0.34
|
| |
-0.55 to +0.55
|
| |
0
|
| |
5
|
| |
0.99
|
| |
n/a
|
|
RBQ
|
| | Total | | |
45
|
| |
-3.2 ± 5.8
|
| |
-10.4 to +4.0
|
| |
0.55
|
| |
5
|
| |
0.28
|
| |
0.22
|
| |
-0.8 ± 3.3
|
| |
-4.9 to 3.3
|
| |
0.24
|
| |
5
|
| |
0.62
|
| |
0.47
|
|
Name
|
| |
Age
|
| |
Position(s)
|
|
Howard J. Weisman | | |
63
|
| | 首席执行官兼三级董事 | |
Stephen D. Sheldon | | |
43
|
| | 首席财务官 | |
Michael Derby | | |
49
|
| |
董事会执行主席、二级董事
|
|
Zachary Rome | | |
38
|
| | 首席运营官兼一级董事 | |
Karen LaRochelle | | |
56
|
| | Class II Director | |
John F. Coelho | | |
53
|
| | Class III Director | |
Charles J. Casamento | | |
77
|
| | Class I Director | |
| | |
Annual Compensation
|
| |||||||||||||||
姓名和主要职务
|
| |
Salary
|
| |
Bonus
|
| |
TOTAL
|
| |||||||||
Howard J. Weisman
首席执行官 |
| | | $ | 400,000 | | | | | $ | 158,333 | | | | | $ | 558,333 | | |
Michael Derby
Executive Chairman |
| | | $ | 325,000 | | | | | $ | 81,250 | | | | | $ | 406,250 | | |
David Hough
前首席医疗官(1) |
| | | $ | 253,125 | | | | | $ | 74,375 | | | | | $ | 327,500 | | |
| | |
Fees Earned or
Paid in Cash |
| |
All Other
Compensation Total |
| ||||||||||||
Name
|
| |
($)
|
| |
($)
|
| |
($)
|
| |||||||||
Karen Dawes(1)
|
| | | | 52,250 | | | | | | — | | | | | | 52,250 | | |
Karen LaRochelle
|
| | | | 50,000 | | | | | | — | | | | | | 50,000 | | |
Paul Wotton(2)
|
| | | | 42,500 | | | | | | — | | | | | | 42,500 | | |
Robert F. Apple(3)
|
| | | | 65,000 | | | | | | — | | | | | | 65,000 | | |
Name of Beneficial Owner
|
| |
Number of
Shares Beneficially Owned |
| |
Percentage
Owned |
| ||||||
5% Stockholders | | | | | | | | | | | | | |
TardiMed Sciences, LLC(4)
|
| | | | 7,336,745 | | | | | | 61.0% | | |
Blue Cane Partners, LLC(5)
|
| | | | 1,193,339 | | | | | | 9.9% | | |
Amar Foundation(6)
|
| | | | 1,193,339 | | | | | | 9.9% | | |
董事和高管 | | | | | | | | | | | | | |
Stephen D. Sheldon(7)
|
| | | | 33,779 | | | | | | * | | |
Howard J. Weisman
|
| | | | — | | | | | | — | | |
Michael Derby(8)
|
| | | | 7,336,745 | | | | | | 61.0% | | |
Zachary Rome
|
| | | | — | | | | | | * | | |
Karen LaRochelle
|
| | | | — | | | | | | — | | |
John F. Coelho
|
| | | | 18,795 | | | | | | * | | |
Charles J. Casamento
|
| | | | — | | | | | | — | | |
全体董事和高管(7人)
|
| | | | 7,389,319 | | | | | | 61.3% | | |
Selling Stockholder
|
| |
Shares
Beneficially Owned Before this Offering |
| |
Percentage of
Outstanding Common Shares Beneficially Owned Before this Offering |
| |
Shares to be
Sold in this Offering |
| |
Percentage of
Outstanding Shares Beneficially Owned After this Offering |
| ||||||||||||
林肯公园资本基金有限责任公司(1)
|
| | | | 198,974(2) | | | | | | 1.7% | | | | | | 13,102,199(3) | | | | | | 0%(4) | | |
假设每股平均收购价
|
| |
Number of
Registered Shares to be Issued if Full Purchase(1) |
| |
Percentage of
Outstanding Shares After Giving Effect to the Issuance to Lincoln Park(2) |
| |
Gross Proceeds to
Us from the Sale of Shares to Lincoln Park Under the Purchase Agreement |
| |||||||||
$0.50
|
| | | | 2,155,743(3) | | | | | | 16.6% | | | | | $ | 1,077,872 | | |
$1.00
|
| | | | 2,155,743(3) | | | | | | 16.6% | | | | | $ | 2,155,743 | | |
$1.55(4) | | | | | 12,903,225 | | | | | | 52.5% | | | | | $ | 19,999,998 | | |
$2.00
|
| | | | 10,000,000 | | | | | | 46.3% | | | | | $ | 20,000,000 | | |
$4.00
|
| | | | 5,000,000 | | | | | | 30.5% | | | | | $ | 20,000,000 | | |
| | |
Page No.
|
| |||
Balance Sheets as of December 31, 2021 and December 31, 2020
|
| | | | F-3 | | |
截至2021年12月31日和2020年12月31日的年度营业报表
|
| | | | F-4 | | |
截至2021年12月31日和2020年12月31日止年度股东亏损表
|
| | | | F-5 | | |
截至2021年12月31日和2020年12月31日的年度现金流量表
|
| | | | F-6 | | |
财务报表附注
|
| | | | F-7 | | |
截至2022年9月30日(未经审计)和2021年12月31日的简明资产负债表
|
| | | | F-23 | | |
截至2022年和2021年9月30日的三个月和九个月未经审计的经营简明报表
|
| | | | F-24 | | |
截至2022年和2021年9月30日的三个月和九个月未经审计的股东赤字变动简明报表
|
| | | | F-25 | | |
截至2022年9月30日的9个月未经审计的现金流量简明报表
and 2021 |
| | | | F-27 | | |
财务报表附注
|
| | | | F-28 | | |
| | |
December 31,
2021 |
| |
December 31,
2020 |
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | |
Cash
|
| | | $ | 444,087 | | | | | $ | 1,123,625 | | |
Total current assets
|
| | | | 444,087 | | | | | | 1,123,625 | | |
延期发售成本
|
| | | | 204,779 | | | | | | — | | |
Total assets
|
| | | $ | 648,866 | | | | | $ | 1,123,625 | | |
负债和股东亏损 | | | | | | | | | | | | | |
流动负债 | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 736,251 | | | | | $ | 346,094 | | |
应付帐款 - 关联方
|
| | | | 750 | | | | | | 102,803 | | |
Accrued expenses
|
| | | | 680,026 | | | | | | 578,524 | | |
Accrued interest
|
| | | | — | | | | | | 55,175 | | |
Notes payable, net of discount of $0 and $2,550,780
|
| | | | — | | | | | | 611,641 | | |
SAFE liability
|
| | | | 4,824,217 | | | | | | — | | |
Warrant liability
|
| | | | 4,516,485 | | | | | | 4,057,927 | | |
流动负债总额
|
| | | | 10,757,729 | | | | | | 5,752,164 | | |
Total liabilities
|
| | | | 10,757,729 | | | | | | 5,752,164 | | |
承付款和或有事项(附注10) | | | | | | | | | | | | | |
股东亏损 | | | | | | | | | | | | | |
Preferred shares, par value $0.0001; 2,696,439 shares authorized; 2,696,439
2021年12月31日和2020年12月31日发行和发行的股票 分别为:总计2,808,148美元的清算优先权 |
| | | | 270 | | | | | | 270 | | |
Common stock, par value $0.0001; 20,000,000 shares authorized at
December 31, 2021 and 2020; 6,913,492 and 5,775,898 shares issued and 分别于2021年12月31日和2020年12月31日未偿还 |
| | | | 691 | | | | | | 578 | | |
新增实收资本
|
| | | | 8,828,425 | | | | | | 4,079,891 | | |
Accumulated deficit
|
| | | | (18,938,249) | | | | | | (8,709,278) | | |
股东亏损总额
|
| | | | (10,108,863) | | | | | | (4,628,539) | | |
总负债和股东赤字
|
| | | $ | 648,866 | | | | | $ | 1,123,625 | | |
| | |
Years Ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
运营费用 | | | | | | | | | | | | | |
一般和行政
|
| | | $ | 4,973,245 | | | | | $ | 4,629,070 | | |
研发
|
| | | | 2,224,555 | | | | | | 936,776 | | |
总运营费用
|
| | | | 7,197,800 | | | | | | 5,565,846 | | |
Loss from operations
|
| | | | (7,197,800) | | | | | | (5,565,846) | | |
Other income (expense): | | | | | | | | | | | | | |
Interest expense
|
| | | | (2,805,856) | | | | | | (609,458) | | |
Loss on issuance of debt
|
| | | | — | | | | | | (53,541) | | |
债务清偿损失
|
| | | | — | | | | | | (23,284) | | |
票据折算收益
|
| | | | 59,890 | | | | | | — | | |
外管局公允价值变动
|
| | | | 175,783 | | | | | | — | | |
公允价值变动担保责任
|
| | | | (458,558) | | | | | | (1,569,383) | | |
衍生工具公允价值变动
|
| | | | — | | | | | | (4,496) | | |
Other income
|
| | | | 2,665 | | | | | | — | | |
Other expense
|
| | | | (5,095) | | | | | | — | | |
Total other expense
|
| | | | (3,031,171) | | | | | | (2,260,162) | | |
Net loss
|
| | | $ | (10,228,971) | | | | | $ | (7,826,008) | | |
减去:应计优先股和股票分红
|
| | | | — | | | | | | (19,442) | | |
减:优先股的视为股息 - 受益转换功能
|
| | | | — | | | | | | (1,452,422) | | |
普通股股东应占净亏损
|
| | | $ | (10,228,971) | | | | | $ | (9,297,872) | | |
基本和稀释后的加权平均流通股数量
|
| | | | 6,666,005 | | | | | | 5,775,898 | | |
普通股股东每股基本和稀释后净亏损
|
| | | $ | (1.53) | | | | | $ | (1.61) | | |
| | |
Preferred Units
|
| | |
Preferred Stock
|
| |
Common Units
|
| |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Units
|
| |
Amount
|
| | |
Shares
|
| |
Amount
|
| |
Units
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2019
|
| | | | 1,516,041 | | | | | $ | 765,527 | | | | | |
|
—
|
| | | |
|
—
|
| | | | | 5,775,898 | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | (863,828) | | | | | $ | (863,828) | | |
Contribution from
TardiMed |
| | | | 940,000 | | | | | | 470,000 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
投资者贡献
|
| | | | 100,000 | | | | | | 50,000 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
TardiMed的非现金捐助
|
| | | | 72,428 | | | | | | 36,214 | | | | | | | 29,086 | | | | | | 3 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 14,540 | | | | | | — | | | | | | 14,543 | | |
优先股转换为优先股
|
| | | | (2,667,353) | | | | | | (1,341,183) | | | | | | | 2,667,353 | | | | | | 267 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,340,916 | | | | | | — | | | | | | 1,341,183 | | |
将常用单位转换为普通股
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | (5,775,898) | | | | | | — | | | | | | 5,775,898 | | | | | | 578 | | | | | | (578) | | | | | | — | | | | | | — | | |
股票薪酬
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,262,093 | | | | | | — | | | | | | 2,262,093 | | |
应计优先股和股票股利
|
| | | | 38,884 | | | | | | 19,442 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (19,442) | | | | | | (19,442) | | |
中的受益转换功能
connection with notes payable |
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 462,920 | | | | | | — | | | | | | 462,920 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (7,826,008) | | | | | | (7,826,008) | | |
Balance at December 31, 2020
|
| | | | — | | | | | | — | | | | | | | 2,696,439 | | | | | $ | 270 | | | | | | — | | | | | $ | — | | | | | | 5,775,898 | | | | | $ | 578 | | | | | $ | 4,079,891 | | | | | $ | (8,709,278) | | | | | $ | (4,628,539) | | |
Common stock issued in
与转换的连接 of notes payable |
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,137,594 | | | | | | 113 | | | | | | 3,412,669 | | | | | | — | | | | | | 3,412,782 | | |
股票薪酬
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,335,865 | | | | | | — | | | | | | 1,335,865 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (10,228,971) | | | | | | (10,228,971) | | |
Balance at December 31, 2021
|
| | | | — | | | | | $ | — | | | | | | | 2,696,439 | | | | | $ | 270 | | | | | | — | | | | | $ | — | | | | | | 6,913,492 | | | | | $ | 691 | | | | | $ | 8,828,425 | | | | | $ | (18,938,249) | | | | | $ | (10,108,863) | | |
| | |
Years ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
经营活动产生的现金流 | | | | | | | | | | | | | |
Net loss
|
| | | $ | (10,228,971) | | | | | $ | (7,826,008) | | |
将净亏损与经营活动中使用的现金净额进行调整: | | | | | | | | | | | | | |
股票薪酬
|
| | | | 1,335,865 | | | | | | 2,262,093 | | |
债务贴现摊销
|
| | | | 2,550,780 | | | | | | 551,752 | | |
Loss on issuance of debt
|
| | | | — | | | | | | 53,541 | | |
债务清偿损失
|
| | | | — | | | | | | 23,284 | | |
外管局公允价值变动
|
| | | | (175,783) | | | | | | — | | |
票据折算收益
|
| | | | (59,890) | | | | | | — | | |
公允价值变动担保责任
|
| | | | 458,558 | | | | | | 1,569,383 | | |
衍生工具公允价值变动
|
| | | | — | | | | | | 4,496 | | |
非现金利息支出
|
| | | | 255,076 | | | | | | — | | |
TardiMed的非现金捐助
|
| | | | — | | | | | | 50,757 | | |
资产和负债变动:
|
| | | | | | | | | | | | |
Accounts payable
|
| | | | 352,277 | | | | | | 305,071 | | |
应付帐款 - 关联方
|
| | | | (102,053) | | | | | | 87,478 | | |
Accrued expenses
|
| | | | 101,502 | | | | | | 511,624 | | |
Accrued interest
|
| | | | — | | | | | | 57,707 | | |
经营活动中使用的净现金
|
| | | | (5,512,639) | | | | | | (2,348,822) | | |
融资活动产生的现金流 | | | | | | | | | | | | | |
安全投资收益
|
| | | | 5,000,000 | | | | | | — | | |
延期发行费用的支付
|
| | | | (166,899) | | | | | | — | | |
TardiMed的贡献
|
| | | | — | | | | | | 470,000 | | |
应付票据收益
|
| | | | — | | | | | | 2,927,500 | | |
第三方投资者出资
|
| | | | — | | | | | | 50,000 | | |
融资活动提供的现金净额
|
| | | | 4,833,101 | | | | | | 3,447,500 | | |
现金净(减)增
|
| | | | (679,538) | | | | | | 1,098,678 | | |
Cash, beginning of year
|
| | | | 1,123,625 | | | | | | 24,947 | | |
Cash, end of year
|
| | | $ | 444,087 | | | | | $ | 1,123,625 | | |
非现金融资活动: | | | | | | | | | | | | | |
因转换应付票据而发行的普通股
|
| | | $ | 3,412,782 | | | | | $ | — | | |
Unpaid offering costs
|
| | | $ | 37,880 | | | | | $ | — | | |
优先股的视为股息 - 受益转换功能
|
| | | $ | — | | | | | $ | 1,452,422 | | |
优先股转换为优先股
|
| | | $ | — | | | | | $ | 1,341,183 | | |
与应付票据相关的有益转换功能
|
| | | $ | — | | | | | $ | 462,920 | | |
应计优先股和股票股利
|
| | | $ | — | | | | | $ | 19,442 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Preferred stock
|
| | | | 1,557,435 | | | | | | 1,557,435 | | |
未授予的限制性股票单位
|
| | | | — | | | | | | 1,377,999 | | |
Common stock warrants
|
| | | | 1,034,176 | | | | | | 1,034,176 | | |
Convertible notes
|
| | | | — | | | | | | 1,034,177 | | |
SAFE investment(1)
|
| | | | 414,808 | | | | | | — | | |
Total
|
| | | | 3,006,419 | | | | | | 5,003,787 | | |
| | |
Year Ended
December 31, 2021 |
|
Dividend yield
|
| |
—
|
|
预期价格波动
|
| |
50.0%
|
|
Risk free interest rate
|
| |
0.06% – 0.07%
|
|
Expected term (in years)
|
| |
1.0 – 5.0
|
|
| | |
Years Ended December 31,
|
| |||
| | |
2021
|
| |
2020
|
|
Dividend yield
|
| |
—
|
| |
—
|
|
预期价格波动
|
| |
76.8% – 112.1%
|
| |
108.7% – 114.4%
|
|
Risk free interest rate
|
| |
0.05% – 1.09%
|
| |
0.10% – 0.38%
|
|
Expected term (in years)
|
| |
1.0 – 5.0
|
| |
1.0 – 5.0
|
|
| | |
Year Ended
December 31, 2020 |
|
或有利率
|
| |
15.0%
|
|
Interest rate
|
| |
10.0%
|
|
Expected term
|
| |
0.8 – 1.0
|
|
| | |
Fair value measured at December 31, 2021
|
| |||||||||||||||||||||
| | |
Total carrying
value at December 31, 2021 |
| |
Quoted prices in
active markets (Level 1) |
| |
Significant other
observable inputs (Level 2) |
| |
Significant
unobservable inputs (Level 3) |
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
SAFE liability
|
| | | $ | 4,824,217 | | | | | $ | — | | | | | $ | — | | | | | $ | 4,824,217 | | |
Warrant liability
|
| | | $ | 4,516,485 | | | | | $ | — | | | | | $ | — | | | | | $ | 4,516,485 | | |
| | |
Fair value measured at December 31, 2020
|
| |||||||||||||||||||||
| | |
Total carrying
value at December 31, 2020 |
| |
Quoted prices in
active markets (Level 1) |
| |
Significant other
observable inputs (Level 2) |
| |
Significant
unobservable inputs (Level 3) |
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Warrant liability
|
| | | $ | 4,057,927 | | | | | $ | — | | | | | $ | — | | | | | $ | 4,057,927 | | |
Contingent Interest
|
| | | $ | 59,890 | | | | | $ | — | | | | | $ | — | | | | | $ | 59,890 | | |
| | |
SAFE Liability
|
| |
Warrant Liability
|
| |
Contingent Interest
|
| |||||||||
Balance at December 31, 2019
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
发行与可转换票据相关的权证
|
| | | | — | | | | | | 2,488,544 | | | | | | — | | |
与应付票据有关的或有利息
|
| | | | — | | | | | | — | | | | | | 55,394 | | |
Change in fair value
|
| | | | — | | | | | | 1,569,383 | | | | | | 4,496 | | |
Balance at December 31, 2020
|
| | | $ | — | | | | | $ | 4,057,927 | | | | | $ | 59,890 | | |
票据折算收益
|
| | | | — | | | | | | — | | | | | | (59,890) | | |
Issuance of SAFE
|
| | | | 5,000,000 | | | | | | — | | | | | | — | | |
Change in fair value
|
| | | | (175,783) | | | | | | 458,558 | | | | | | — | | |
Balance at December 31, 2021
|
| | | $ | 4,824,217 | | | | | $ | 4,516,485 | | | | | $ | — | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Accrued expenses: | | | | | | | | | | | | | |
员工及相关费用
|
| | | $ | 680,026 | | | | | $ | 499,752 | | |
研发
|
| | | | — | | | | | | 4,000 | | |
Professional fees
|
| | | | — | | | | | | 74,772 | | |
应计费用合计
|
| | | $ | 680,026 | | | | | $ | 578,524 | | |
Issuance date
|
| |
Principal
Balance |
| |
Contingent
Interest |
| |
Unamortized
Debt Discount |
| |
Notes
Payable as of December 31, 2020 |
| ||||||||||||
October 26, 2020
|
| | | $ | 2,250,000 | | | | | $ | 43,445 | | | | | $ | (1,843,151) | | | | | $ | 450,295 | | |
October 29, 2020
|
| | | | 750,000 | | | | | | 14,470 | | | | | | (620,548) | | | | | | 143,922 | | |
November 6, 2020
|
| | | | 102,532 | | | | | | 1,974 | | | | | | (87,082) | | | | | | 17,424 | | |
| | | | $ | 3,102,532 | | | | | $ | 59,890 | | | | | $ | (2,550,780) | | | | | $ | 611,641 | | |
|
可转换票据本金价值
|
| | | $ | 3,102,532 | | |
|
原始出库折扣
|
| | | | (172,500) | | |
|
将收益分配到认股权证负债所产生的折扣
|
| | | | (2,488,544) | | |
|
受益转换功能带来的折扣
|
| | | | (462,920) | | |
|
摊销折扣
|
| | | | 551,752 | | |
|
Loss on issuance of debt
|
| | | | 53,541 | | |
|
债务清偿损失
|
| | | | 23,284 | | |
|
衍生工具公允价值变动
|
| | | | 4,496 | | |
|
高级担保可转换票据账面净值
|
| | | $ | 611,641 | | |
| | |
Number of Shares
|
| |
Weighted Average
Grant-Date Fair Value |
| ||||||
Unvested as of January 1, 2020
|
| | | | — | | | | | $ | — | | |
Granted
|
| | | | 1,377,999 | | | | | $ | 8.98 | | |
Unvested as of December 31, 2020
|
| | | | 1,377,999 | | | | | $ | 8.98 | | |
Forfeited
|
| | | | (1,377,999) | | | | | $ | 8.98 | | |
Unvested as of December 31, 2021
|
| | | | — | | | | | $ | — | | |
| | |
Current
|
| |
Deferred
|
| |
Total
|
| |||||||||
Federal
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
State
|
| | | | — | | | | | | — | | | | | | — | | |
Foreign
|
| | | | — | | | | | | — | | | | | | — | | |
Total
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | |
As of December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
净营业亏损结转
|
| | | $ | 2,030 | | | | | $ | 797 | | |
研发学分
|
| | | | 11 | | | | | | 11 | | |
Accrued expenses
|
| | | | 166 | | | | | | 144 | | |
股权薪酬
|
| | | | — | | | | | | 591 | | |
其他暂时性分歧
|
| | | | — | | | | | | 20 | | |
递延税项总资产
|
| | | | 2,207 | | | | | | 1,563 | | |
Valuation allowance
|
| | | | (2,207) | | | | | | (1,563) | | |
Net deferred tax asset
|
| | | $ | — | | | | | $ | — | | |
| | |
For the years ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
按法定税率计提的税金拨备
|
| | | | 21.0% | | | | | | 21.0% | | |
扣除联邦福利后的州税
|
| | | | 3.7% | | | | | | 3.9% | | |
基于份额的薪酬
|
| | | | (9.2)% | | | | | | —% | | |
Debt conversion
|
| | | | (6.7)% | | | | | | —% | | |
Permanent items
|
| | | | 0.4% | | | | | | —% | | |
Other
|
| | | | —% | | | | | | (0.7)% | | |
Warrant liability
|
| | | | (0.9)% | | | | | | (4.2)% | | |
估值准备金变动
|
| | | | (8.3)% | | | | | | (20.0)% | | |
所得税拨备(福利)
|
| | | | —% | | | | | | —% | | |
| | |
September 30,
2022 |
| |
December 31,
2021 |
| | ||||||||
| | |
(Unaudited)
|
| | | | | | | | |||||
ASSETS | | | | | | | | | | | | | | | ||
Current assets | | | | | | | | | | | | | | | ||
Cash
|
| | | $ | 5,563,332 | | | | | $ | 444,087 | | | | ||
预付及其他流动资产
|
| | | | 416,439 | | | | | | — | | | | ||
Total current assets
|
| | | | 5,979,771 | | | | | | 444,087 | | | | ||
延期发售成本
|
| | | | — | | | | | | 204,779 | | | | ||
Total assets
|
| | | $ | 5,979,771 | | | | | | 648,866 | | | | ||
负债和股东权益(亏损) | | | | | | | | | | | | | | | ||
流动负债 | | | | | | | | | | | | | | | ||
Accounts payable
|
| | | $ | 2,688,533 | | | | | $ | 736,251 | | | | ||
应付帐款 - 关联方
|
| | | | 132,000 | | | | | | 750 | | | | ||
Accrued expenses
|
| | | | 614,450 | | | | | | 680,026 | | | | ||
Notes payable – fair value
|
| | | | 156,486 | | | | | | — | | | | ||
SAFE liability
|
| | | | — | | | | | | 4,824,217 | | | | ||
Warrant liability
|
| | | | — | | | | | | 4,516,485 | | | | ||
流动负债总额
|
| | | | 3,591,469 | | | | | | 10,757,729 | | | | ||
Total liabilities
|
| | | | 3,591,469 | | | | | | 10,757,729 | | | | ||
承付款和或有事项(注9) | | | | | | | | | | | | | | | ||
股东权益(亏损) | | | | | | | | | | | | | | | ||
优先股,面值$0.0001,授权股份1,000万股: | | | | | | | | | | | | | | | ||
系列种子优先股,授权发行2,696,439股;2022年9月30日没有发行和发行股份,2021年12月31日发行和发行2,696,439股;截至2021年12月31日,清算优先股总额为2,808,148美元
|
| | | | — | | | | | | 270 | | | | ||
X系列优先股,2022年9月30日授权发行500,000股;2022年9月30日已发行和已发行45,316股,2021年12月31日未发行和已发行
|
| | | | 15 | | | | | | — | | | | ||
Common stock, par value $0.0001; 200,000,000 shares authorized at
September 30, 2022 and 20,000,000 shares authorized at December 31, 2021; 11,779,475 and 6,913,492 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively |
| | | | 1,178 | | | | | | 691 | | | | ||
新增实收资本
|
| | | | 30,906,477 | | | | | | 8,828,425 | | | | ||
Accumulated deficit
|
| | | | (28,519,368) | | | | | | (18,938,249) | | | | ||
股东权益合计(亏损)
|
| | | | 2,388,302 | | | | | | (10,108,863) | | | | ||
总负债和股东权益(亏损)
|
| | | $ | 5,979,771 | | | | | | 648,866 | | | | | |
| | |
Three Months
Ended September 30, |
| |
Nine Months
Ended September 30, |
| ||||||||||||||||||
| | |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
| ||||||||||||
运营费用 | | | | | | | | | | | | | | | | | | | | | | | | | |
一般和行政
|
| | | $ | 2,367,711 | | | | | $ | 1,277,287 | | | | | $ | 4,077,491 | | | | | $ | 3,651,218 | | |
研发
|
| | | | 327,268 | | | | | | 437,559 | | | | | | 1,549,397 | | | | | | 1,755,428 | | |
总运营费用
|
| | | | 2,694,979 | | | | | | 1,714,846 | | | | | | 5,626,888 | | | | | | 5,406,646 | | |
Loss from operations
|
| | | | (2,694,979) | | | | | | (1,714,846) | | | | | | (5,626,888) | | | | | | (5,406,646) | | |
Other income (expense): | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (1,309) | | | | | | — | | | | | | (1,309) | | | | | | (2,805,856) | | |
票据折算收益
|
| | | | — | | | | | | — | | | | | | — | | | | | | 59,890 | | |
保险箱折算损失
|
| | | | (5,338,808) | | | | | | — | | | | | | (5,338,808) | | | | | | — | | |
Loss on issuance of debt
|
| | | | (88,234) | | | | | | — | | | | | | (391,246) | | | | | | — | | |
债务清偿损失
|
| | | | (3,940) | | | | | | — | | | | | | (3,940) | | | | | | — | | |
票据公允价值变动
|
| | | | (151,195) | | | | | | — | | | | | | (255,145) | | | | | | — | | |
外管局公允价值变动
|
| | | | (2,827,737) | | | | | | (622,212) | | | | | | 163,025 | | | | | | (3,806,374) | | |
公允价值变动担保责任
|
| | | | (357,411) | | | | | | (789,419) | | | | | | 1,873,192 | | | | | | (4,498,146) | | |
Other income (expense)
|
| | | | — | | | | | | 15,835 | | | | | | — | | | | | | (5,095) | | |
Total other expense
|
| | | | (8,768,634) | | | | | | (1,395,796) | | | | | | (3,954,231) | | | | | | (11,055,581) | | |
Net loss
|
| | | $ | (11,463,613) | | | | | $ | (3,110,642) | | | | | $ | (9,581,119) | | | | | $ | (16,462,227) | | |
基本和稀释后的加权平均流通股数量
|
| | | | 9,177,683 | | | | | | 6,913,492 | | | | | | 7,676,516 | | | | | | 6,582,602 | | |
每股基本和摊薄净亏损
|
| | | $ | (0.87) | | | | | $ | (0.45) | | | | | $ | (1.10) | | | | | $ | (2.50) | | |
| | |
Series Seed
Preferred Stock |
| |
Series X
Preferred Stock |
| |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Equity (Deficit) |
| ||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
Balance at July 1, 2022
|
| | | | 2,696,439 | | | | | | 270 | | | | | | — | | | | | | — | | | | | | 6,913,492 | | | | | $ | 691 | | | | | | 9,158,437 | | | | | $ | (17,055,755) | | | | | | (7,896,357) | | |
发行X系列优先股,净额
of fees |
| | | | — | | | | | | — | | | | | | 3,200 | | | | | | 1 | | | | | | — | | | | | | — | | | | | | 299,999 | | | | | | — | | | | | | 300,000 | | |
将安全责任转换为X系列
preferred stock |
| | | | — | | | | | | — | | | | | | 100,000 | | | | | | 20 | | | | | | — | | | | | | — | | | | | | 9,999,980 | | | | | | — | | | | | | 10,000,000 | | |
发行普通股和认股权证,扣除费用
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,545,454 | | | | | | 154 | | | | | | 6,022,859 | | | | | | — | | | | | | 6,023,013 | | |
发行与转换应付票据相关的普通股
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 238,094 | | | | | | 24 | | | | | | 1,159,476 | | | | | | — | | | | | | 1,159,500 | | |
发行与应付票据转换相关的X系列优先股
|
| | | | — | | | | | | — | | | | | | 2,555 | | | | | | — | | | | | | — | | | | | | — | | | | | | 296,819 | | | | | | — | | | | | | 296,819 | | |
将系列种子优先股转换为普通股
|
| | | | (2,696,439) | | | | | | (270) | | | | | | — | | | | | | — | | | | | | 1,557,435 | | | | | | 156 | | | | | | 114 | | | | | | — | | | | | | — | | |
将X系列优先股转换为普通股
|
| | | | — | | | | | | — | | | | | | (61,689) | | | | | | (6) | | | | | | 1,175,000 | | | | | | 118 | | | | | | (112) | | | | | | — | | | | | | — | | |
换股权证
普通股和X系列优先股 stock |
| | | | — | | | | | | — | | | | | | 1,250 | | | | | | — | | | | | | 350,000 | | | | | | 35 | | | | | | 2,009,172 | | | | | | — | | | | | | 2,009,207 | | |
将认股权证重新分类为股权
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 912,580 | | | | | | — | | | | | | 912,580 | | |
股票薪酬
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,047,153 | | | | | | — | | | | | | 1,047,153 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (11,463,613) | | | | | | (11,463,613) | | |
Balance at September 30, 2022
|
| | | | — | | | | | | — | | | | | | 45,316 | | | | | | 15 | | | | | | 11,779,475 | | | | | $ | 1,178 | | | | | | 30,906,477 | | | | | $ | (28,519,368) | | | | | | 2,388,302 | | |
| | |
Series Seed
Preferred Stock |
| |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance at July 1, 2021
|
| | | | 2,696,439 | | | | | $ | 270 | | | | | | 6,913,492 | | | | | $ | 691 | | | | | $ | 8,331,310 | | | | | $ | (22,060,863) | | | | | | (13,728,592) | | |
股票薪酬
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 272,124 | | | | | | — | | | | | | 272,124 | | |
Net loss
|
| | | | — | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | (3,110,642) | | | | | | (3,110,642) | | |
Balance at September 30, 2021
|
| | | | 2,696,439 | | | | | $ | 270 | | | | | | 6,913,492 | | | | | $ | 691 | | | | | $ | 8,603,434 | | | | | $ | (25,171,505) | | | | | | (16,567,110) | | |
| | |
Series Seed
Preferred Stock |
| |
Series X
Preferred Stock |
| |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Equity (Deficit) |
| ||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
Balance at January 1, 2022
|
| | | | 2,696,439 | | | | | | 270 | | | | | | — | | | | | | — | | | | | | 6,913,492 | | | | | $ | 691 | | | | | | 8,828,425 | | | | | $ | (18,938,249) | | | | | $ | (10,108,863) | | |
发行X系列优先股,扣除费用后的净额
|
| | | | — | | | | | | — | | | | | | 3,200 | | | | | | 1 | | | | | | — | | | | | | — | | | | | | 299,999 | | | | | | — | | | | | | 300,000 | | |
将安全责任转换为X系列优先股
|
| | | | — | | | | | | — | | | | | | 100,000 | | | | | | 20 | | | | | | — | | | | | | — | | | | | | 9,999,980 | | | | | | — | | | | | | 10,000,000 | | |
发行普通股和认股权证,扣除费用
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,545,454 | | | | | | 154 | | | | | | 6,022,859 | | | | | | — | | | | | | 6,023,013 | | |
Issuance of common stock in
与笔记转换的连接 payable |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 238,094 | | | | | | 24 | | | | | | 1,159,476 | | | | | | — | | | | | | 1,159,500 | | |
在
发行X系列优先股
与笔记转换的连接 payable |
| | | | — | | | | | | — | | | | | | 2,555 | | | | | | — | | | | | | — | | | | | | — | | | | | | 296,819 | | | | | | — | | | | | | 296,819 | | |
将系列种子优先股转换为普通股
|
| | | | (2,696,439) | | | | | | (270) | | | | | | — | | | | | | — | | | | | | 1,557,435 | | | | | | 156 | | | | | | 114 | | | | | | — | | | | | | — | | |
转换X系列优先股
to common stock |
| | | | — | | | | | | — | | | | | | (61,689) | | | | | | (6) | | | | | | 1,175,000 | | | | | | 118 | | | | | | (112) | | | | | | — | | | | | | — | | |
换股普通股和X系列优先股的权证
|
| | | | — | | | | | | — | | | | | | 1,250 | | | | | | — | | | | | | 350,000 | | | | | | 35 | | | | | | 2,009,172 | | | | | | — | | | | | | 2,009,207 | | |
将认股权证重新分类为
equity |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 912,580 | | | | | | — | | | | | | 912,580 | | |
股票薪酬
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,377,165 | | | | | | — | | | | | | 1,377,165 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (9,581,119) | | | | | | (9,581,119) | | |
Balance at September 30, 2022
|
| | | | — | | | | | | — | | | | | | 45,316 | | | | | | 15 | | | | | | 11,779,475 | | | | | $ | 1,178 | | | | | $ | 30,906,477 | | | | | $ | (28,519,368) | | | | | $ | 2,388,302 | | |
| | |
Series Seed
Preferred Stock |
| |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance at January 1, 2021
|
| | | | 2,696,439 | | | | | $ | 270 | | | | | | 5,775,898 | | | | | $ | 578 | | | | | $ | 4,079,891 | | | | | $ | (8,709,278) | | | | | $ | (4,628,539) | | |
因转换应付票据而发行的普通股
|
| | | | — | | | | | | — | | | | | | 1,137,594 | | | | | | 113 | | | | | | 3,412,669 | | | | | | — | | | | | | 3,412,782 | | |
股票薪酬
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,110,874 | | | | | | — | | | | | | 1,110,874 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (16,462,227) | | | | | | (16,462,227) | | |
Balance at September 30, 2021
|
| | | | 2,696,439 | | | | | $ | 270 | | | | | | 6,913,492 | | | | | $ | 691 | | | | | $ | 8,603,434 | | | | | $ | (25,171,505) | | | | | $ | (16,567,110) | | |
| | |
Nine Months Ended
September 30, |
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
经营活动产生的现金流 | | | | | | | | | | | | | |
Net loss
|
| | | $ | (9,581,119) | | | | | $ | (16,462,227) | | |
将净亏损与经营活动中使用的现金净额进行调整: | | | | | | | | | | | | | |
股票薪酬
|
| | | | 1,377,165 | | | | | | 1,110,874 | | |
债务贴现摊销
|
| | | | — | | | | | | 2,550,780 | | |
票据公允价值变动
|
| | | | 255,145 | | | | | | — | | |
外管局公允价值变动
|
| | | | (163,025) | | | | | | 3,806,374 | | |
保险箱折算损失
|
| | | | 5,338,808 | | | | | | — | | |
Loss on issuance of debt
|
| | | | 391,246 | | | | | | — | | |
债务清偿损失
|
| | | | 3,940 | | | | | | — | | |
票据折算收益
|
| | | | — | | | | | | (59,890) | | |
公允价值变动担保责任
|
| | | | (1,873,192) | | | | | | 4,498,145 | | |
非现金利息支出
|
| | | | — | | | | | | 255,076 | | |
资产和负债变动: | | | | | | | | | | | | | |
Other current assets
|
| | | | (416,439) | | | | | | — | | |
延期发售成本
|
| | | | 204,779 | | | | | | — | | |
Accounts payable
|
| | | | (65,578) | | | | | | 140,935 | | |
应付帐款 - 关联方
|
| | | | 131,250 | | | | | | (100,138) | | |
Accrued expenses
|
| | | | 1,392,845 | | | | | | (4,179) | | |
经营活动中使用的净现金
|
| | | | (3,004,175) | | | | | | (4,264,250) | | |
融资活动产生的现金流 | | | | | | | | | | | | | |
发行普通股和认股权证的收益,扣除费用
|
| | | | 6,582,450 | | | | | | — | | |
发行可转换本票的收益,扣除手续费后的收益
|
| | | | 1,240,970 | | | | | | — | | |
发行X系列优先股的收益,扣除费用后的净额
|
| | | | 300,000 | | | | | | — | | |
安全投资收益
|
| | | | — | | | | | | 5,000,000 | | |
延期发行费用的支付
|
| | | | — | | | | | | (60,779) | | |
融资活动提供的现金净额
|
| | | | 8,123,420 | | | | | | 4,939,221 | | |
Net increase in cash
|
| | | | 5,119,245 | | | | | | 674,971 | | |
Cash, beginning of period
|
| | | | 444,087 | | | | | | 1,123,625 | | |
Cash, end of period
|
| | | $ | 5,563,332 | | | | | | 1,798,596 | | |
非现金融资活动: | | | | | | | | | | | | | |
因转换应付票据而发行的X系列优先股
|
| | | $ | 296,819 | | | | | $ | — | | |
因转换应付票据而发行的普通股
|
| | | $ | 1,159,500 | | | | | | 3,412,782 | | |
将安全责任转换为X系列优先股
|
| | | $ | 10,000,000 | | | | | | — | | |
换股普通股和X系列优先股的权证
|
| | | $ | 2,009,207 | | | | | | — | | |
将认股权证重新分类为股权
|
| | | $ | 912,580 | | | | | | — | | |
Unpaid offering costs
|
| | | $ | 559,437 | | | | | | — | | |
| | |
September 30,
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
Preferred stock
|
| | | | — | | | | | | 1,557,435 | | |
Series X preferred stock
|
| | | | 863,162 | | | | | | — | | |
未授予的限制性股票单位
|
| | | | 1,582,220 | | | | | | 1,377,999 | | |
Common stock warrants
|
| | | | 587,497 | | | | | | 1,034,176 | | |
SAFE investment
|
| | | | — | | | | | | 414,808 | | |
Convertible notes
|
| | | | 37,259 | | | | | | — | | |
Total | | | | | 3,070,138 | | | | | | 4,384,418 | | |
| | |
July 8, 2022
|
| |
August 3, 2022 –
August 5, 2022 |
| |
Three months
ended September 30, 2022 |
| |
Nine months ended
September 30, 2022 |
|
Dividend yield
|
| |
0%
|
| |
0%
|
| |
0%
|
| |
0%
|
|
预期价格波动
|
| |
57.0%
|
| |
57.0%
|
| |
57.0%
|
| |
57.0% – 57.2%
|
|
Risk free interest rate
|
| |
2.96%
|
| |
3.14% – 3.29%
|
| |
2.8% – 4.05%
|
| |
2.8% – 4.05%
|
|
Expected term (in years)
|
| |
1.0
|
| |
1.0
|
| |
0.7 – 0.9
|
| |
0.7 – 0.9
|
|
| | |
August 2,
2022 |
| |
January 1,
2022 – August 2, 2022 |
|
Dividend yield
|
| |
0%
|
| |
0%
|
|
预期价格波动
|
| |
50.0%
|
| |
50.0%
|
|
Risk free interest rate
|
| |
3.08%
|
| |
1.35% – 3.08%
|
|
Expected term (in years)
|
| |
1.5
|
| |
0.8 – 1.5
|
|
| | |
July 2022
|
| |
August 26, 2022
|
| |
January 1 2022 –
August 26, 2022 |
|
Dividend yield
|
| |
0%
|
| |
0%
|
| |
0%
|
|
预期价格波动
|
| |
57.0%
|
| |
57.0%
|
| |
57.0% – 105.0%
|
|
Risk free interest rate
|
| |
2.70% – 2.82%
|
| |
2.39% – 3.40%
|
| |
0.17% – 3.40%
|
|
Expected term (in years)
|
| |
5.0
|
| |
0.1 – 4.9
|
| |
0.1 – 4.0
|
|
| | |
Fair value measured at September 30, 2022
|
| |||||||||||||||||||||
| | |
Total carrying
value at September 30, 2022 |
| |
Quoted prices in active
markets (Level 1) |
| |
Significant other
observable inputs (Level 2) |
| |
Significant
unobservable inputs (Level 3) |
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible notes
|
| | | $ | 156,486 | | | | | $ | — | | | | | $ | — | | | | | $ | 156,486 | | |
| | |
Fair value measured at December 31, 2021
|
| |||||||||||||||||||||
| | |
Total carrying
value at December 31, 2021 |
| |
Quoted prices in active
markets (Level 1) |
| |
Significant other
observable inputs (Level 2) |
| |
Significant
unobservable inputs (Level 3) |
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
SAFE liability
|
| | | $ | 4,824,217 | | | | | $ | — | | | | | $ | — | | | | | $ | 4,824,217 | | |
Warrant liability
|
| | | $ | 4,516,485 | | | | | $ | — | | | | | $ | — | | | | | $ | 4,516,485 | | |
| | |
Convertible Notes
|
| |
SAFE Liability
|
| |
Warrant Liability
|
| |||||||||
Balance at December 31, 2021
|
| | | $ | — | | | | | $ | 4,824,217 | | | | | $ | 4,516,485 | | |
发行可转换票据和认股权证
|
| | | | 1,353,720 | | | | | | — | | | | | | 278,494 | | |
将安全责任转换为X系列优先股
|
| | | | — | | | | | | (10,000,000) | | | | | | — | | |
发行与转换应付票据相关的普通股
|
| | | | (1,159,500) | | | | | | — | | | | | | — | | |
发行与应付票据转换相关的X系列优先股
|
| | | | (296,819) | | | | | | — | | | | | | — | | |
换取普通股和X系列股票的权证
preferred stock |
| | | | — | | | | | | — | | | | | | (2,009,207) | | |
债务清偿损失
|
| | | | 3,940 | | | | | | — | | | | | | — | | |
Change in fair value
|
| | | | 255,145 | | | | | | (163,025) | | | | | | (1,873,192) | | |
将认股权证重新分类为股权
|
| | | | — | | | | | | — | | | | | | (912,580) | | |
保险箱折算损失
|
| | | | — | | | | | | 5,338,808 | | | | | | — | | |
Balance at September 30, 2022
|
| | | $ | 156,486 | | | | | $ | — | | | | | $ | — | | |
| | |
September 30,
2022 |
| |
December 31,
2021 |
| ||||||
| | |
(Unaudited)
|
| | | | | | | |||
员工及相关费用
|
| | | $ | 50,335 | | | | | $ | 680,026 | | |
董事和高级职员保险
|
| | | | 385,362 | | | | | | — | | |
Professional fees
|
| | | | 153,995 | | | | | | — | | |
研发
|
| | | | 24,758 | | | | | | — | | |
应计费用合计
|
| | | $ | 614,450 | | | | | $ | 680,026 | | |
| | |
Three Months Ended
September 30, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
| ||||||||||||
Canceled stock options
|
| | | $ | 119,829 | | | | | $ | 272,124 | | | | | $ | 449,840 | | | | | $ | 1,110,874 | | |
Restricted stock units
|
| | | | 927,324 | | | | | | — | | | | | | 927,325 | | | | | | — | | |
Total
|
| | | $ | 1,047,153 | | | | | $ | 272,124 | | | | | $ | 1,377,165 | | | | | $ | 1,110,874 | | |
| | |
Number of Shares
|
| |
Weighted Average
Grant-Date Fair Value |
| ||||||
Unvested as of December 31, 2021
|
| | | | — | | | | | $ | — | | |
Granted
|
| | | | 1,885,500 | | | | | $ | 5.25 | | |
Forfeited
|
| | | | (291,500) | | | | | $ | 5.25 | | |
Vested
|
| | | | (11,780) | | | | | $ | 5.26 | | |
Unvested as of September 30, 2022
|
| | | | 1,582,220 | | | | | $ | 5.25 | | |